(Q35162912)

6 August 2017

1 reference

title

ECT of major depressed patients in relation to biological and clinical variables: a brief overview (English)

1 reference

6 August 2017

Björn Wahlund

1

1 reference

PubMed ID

12827140

6 August 2017

Dietrich von Rosen

series ordinal

2

1 reference

PubMed ID

12827140

6 August 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

6 August 2017

Neuropsychopharmacology

1 reference

6 August 2017

28 Suppl 1

1 reference

6 August 2017

S21-6

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.npp.1300135

6 August 2017

0 references

cites work

Prolactin and thyrotropin in serum during electroconvulsive therapy in patients with major depressive illness.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Effects of electroconvulsive therapy on plasma vasopressin and oxytocin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

The hippocampus in patients treated with electroconvulsive therapy: a proton magnetic resonance spectroscopic imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Plasma cortisol, PRL, ACTH, AVP and corticotrophin releasing hormone responses to direct current cardioversion and electroconvulsive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Effects of chronic antidepressant drug administration and electroconvulsive shock on locus coeruleus electrophysiologic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Mechanism underlying the therapeutic effects of electroconvulsive therapy (ECT) on depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Neuropeptide Y in male and female brains of Flinders Sensitive Line, a rat model of depression. Effects of electroconvulsive stimuli.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Electrical stimulation of rat medial prefrontal cortex enhances forebrain serotonin output: implications for electroconvulsive therapy and transcranial magnetic stimulation in depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Plasma noradrenaline response to electroconvulsive therapy in depressive illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Basal plasma dehydroepiandrosterone sulfate level: a possible predictor for response to electroconvulsive therapy in depressed psychotic inpatients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

ECS-induced dopamine release: effects of electrode placement, anticonvulsant treatment, and stimulus intensity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. I. Global analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Decreased regional brain metabolism after ect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

The N-methyl-D-aspartate receptor, synaptic plasticity, and depressive disorder. A critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Seizures, memory and synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

How antidepressants work: new perspectives on the pathophysiology of depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Electrophysiological and hormonal responses to three types of electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

The effects of electroconvulsive therapy on quantitative electroencephalograms. Relationship to clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Cortical grey matter reductions associated with treatment-resistant chronic unipolar depression. Controlled magnetic resonance imaging study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Prolactin in partial epilepsy: an indicator of limbic seizures

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

The effect of limbic and extralimbic electrical stimulations upon prolactin secretion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Electroconvulsive stimulation and synaptic plasticity in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Repeated ECS and fluoxetine administration have equivalent effects on hippocampal synaptic plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Immediate increases in plasma prolactin and neurophysin but not other hormones after electroconvulsive therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Single and repeated electroconvulsive shocks activate dopaminergic and 5-hydroxytryptaminergic neurotransmission in the frontal cortex of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

Relation of electroencephalographic delta activity to behavioral response in electroshock; quantitative serial studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Neurotrophins require distinct extracellular signals to promote the survival of CNS neurons in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Mossy fiber sprouting induced by repeated electroconvulsive shock seizures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Quantitative EEG during seizures induced by electroconvulsive therapy: relations to treatment modality and clinical features. II. Topographic analyses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Increased neurogenesis in a model of electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Regional cerebral blood flow in mood disorders, V.: Effects of antidepressant medication in late-life depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

EEG manifestations during ECT: effects of electrode placement and stimulus intensity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Electroconvulsive seizures modulate levels of thyrotropin releasing hormone and related peptides in rat hypothalamus, cingulate and lateral cerebellum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Changes in the platelet intracellular calcium response to serotonin in patients with major depression treated with electroconvulsive therapy: state or trait marker status

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Diminished TSH release after a course of ECT: altered monoamine function or seizure activity?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Treatment outcome, seizure duration, and the neurophysin response to ECT

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Neurogenesis in the dentate gyrus of the rat following electroconvulsive shock seizures

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Oxytocin as a possible mediator of SSRI-induced antidepressant effects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Effects of electroconvulsive therapy on peripheral adrenoceptors, plasma, noradrenaline, MHPG and cortisol in depressed patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Selective effects of ECT on hypothalamic-pituitary activity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Arginine vasopressin, but not corticotropin releasing factor, is a potent stimulator of adrenocorticotropic hormone following electroconvulsive treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

A preliminary study of the effects of electroconvulsive therapy on regional brain glucose metabolism in patients with major depression

1 reference

https://api.crossref.org/works/10.1038%2FSJ.NPP.1300135

7 January 2021

Identifiers

DOI

10.1038/SJ.NPP.1300135

1 reference

6 August 2017

1 reference

PubMed ID

12827140